Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?

References

• Pui C H, Relling M V, Downing J R. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535–1548
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419–1432
   PubMed Web of Science ®Google Scholar
• Freedman A S. Cell surface antigens in leukemias and lymphomas. Cancer Invest 1996; 14: 252–276
   PubMed Web of Science ®Google Scholar
• Uckun F M, Gaynon P S, Sensel M G, Nachman J, Trigg M E, Steinherz P G, et al. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. J Clin Oncol 1997; 15: 2214–2221
   PubMed Web of Science ®Google Scholar
• Schneider N R, Carroll A J, Shuster J J, Pullen D J, Link M P, Borowitz M J, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 2000; 96: 2543–2549
   PubMed Web of Science ®Google Scholar
• Gesk S, Martin-Subero J I, Harder L, Luhmann B, Schlegelberger B, Calasanz M J, et al. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 2003; 17: 738–745
   PubMed Web of Science ®Google Scholar
• Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006; 20: 1496–1510
   PubMed Web of Science ®Google Scholar
• Zalcberg I Q, Silva M L, Abdelhay E, Tabak D G, Ornellas M H, Simoes F V, et al. Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin. Cancer Genet Cytogenet 1995; 84: 32–38
   PubMed Web of Science ®Google Scholar
• Carlotti E, Pettenella F, Amaru R, Slater S, Lister T A, Barbui T, et al. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia. Br J Haematol 2002; 118: 1011–1018
   PubMed Web of Science ®Google Scholar
• Bernard O A, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della V V, Monni R, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495–1504
   PubMed Web of Science ®Google Scholar
• Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004; 103: 442–450
   PubMed Web of Science ®Google Scholar
• Aster J C. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 2005; 82: 295–301
   PubMed Web of Science ®Google Scholar
• Rubnitz J E, Behm F G, Pui C H, Evans W E, Relling M V, Raimondi S C, et al. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia 1997; 11: 1201–1206
   PubMed Web of Science ®Google Scholar
• Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084–1089
   PubMed Web of Science ®Google Scholar
• Heerema N A, Sather H N, Sensel M G, Kraft P, Nachman J B, Steinherz P G, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 1270–1278
   PubMed Web of Science ®Google Scholar
• Lones M A, Heerema N A, Le Beau M M, Sposto R, Perkins S L, Kadin M E, et al. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet 2007; 172: 1–11
   PubMed Web of Science ®Google Scholar
• Tubergen D G, Krailo M D, Meadows A T, Rosenstock J, Kadin M, Morse M, et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol 1995; 13: 1368–1376
   PubMed Web of Science ®Google Scholar
• Amylon M D, Shuster J, Pullen J, Berard C, Link M P, Wharam M, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 1999; 13: 335–342
   PubMed Web of Science ®Google Scholar
• Pinkerton C R. The continuing challenge of treatment for non-Hodgkin's lymphoma in children. Br J Haematol 1999; 107: 220–234
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig W D, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 2000; 95: 416–421
   PubMed Web of Science ®Google Scholar
• Sachdeva M U, Ahluwalia J, Das R, Varma N, Garewal G. Role of FAB classification of acute leukemias in era of immunophenotyping. Ind J Pathol Microbiol 2006; 49: 524–527
   PubMedGoogle Scholar
• Vilmer E, Suciu S, Ferster A, Bertrand Y, Cave H, Thyss A, et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia 2000; 14: 2257–2266
   PubMed Web of Science ®Google Scholar
• Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. J Clin Oncol 2001; 19: 1935–1942
   PubMed Web of Science ®Google Scholar
• van der Werff Ten Bosch, Suciu S, Thyss A, Bertrand Y, Norton L, Mazingue F, et al. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia 2005; 19: 721–726
   PubMed Web of Science ®Google Scholar
• Bene M C, Castoldi G, Knapp W, Ludwig W D, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• ISCN 2005: An International Sysem for Human Cytogenetic Nomenclature (2005), L Shaffer, N Tommerup. S. Karger, Basel 2005
   Google Scholar
• Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 2005; 19: 358–366
   PubMed Web of Science ®Google Scholar
• Lu Y J, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, et al. Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci USA 2001; 98: 9197–9202
   PubMed Web of Science ®Google Scholar
• Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen A M, Lundsteen C. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 1998; 31: 163–173
   PubMedGoogle Scholar
• Vanhentenrijk V, Wolf-Peeters C, Wlodarska I. Comparative expressed sequence hybridization studies of hairy cell leukemia show uniform expression profile and imprint of spleen signature. Blood 2004; 104: 250–255
   PubMed Web of Science ®Google Scholar
• Saeed A I, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374–378
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Schrappe M, et al. The impact of age and sex on incidence, biology and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Ann Oncol 2005; 16: 61
   Web of Science ®Google Scholar
• Escalon M P, Liu N S, Yang Y, Hess M, Walker P L, Smith T L, et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer 2005; 103: 2091–2098
   PubMed Web of Science ®Google Scholar
• Pullen J, Shuster J J, Link M, Borowitz M, Amylon M, Carroll A J, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999; 13: 1696–1707
   PubMed Web of Science ®Google Scholar
• Roper M, Crist W M, Metzgar R, Ragab A H, Smith S, Starling K, et al. Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 1983; 61: 830–837
   PubMed Web of Science ®Google Scholar
• Raetz E A, Perkins S L, Bhojwani D, Smock K, Philip M, Carroll W L, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatric Blood Cancer 2006; 47: 130–140
   PubMed Web of Science ®Google Scholar
• Uyttebroeck A, Suciu S, Bertrand Y, Laureys G, Robert A, Paquement H. Treatment of childhood T-cell lymphoblastic non-Hodgkin lymphoma according to the strategy for acute lymphoblastic leukemia: long-term results of the EORTC 58881 trial. Blood 2001; 98: 806a
   Google Scholar